O2 Concepts® introduces Oxlife Liberty®

O2 Concepts® introduces Oxlife Liberty®: A revolutionary advance in portable oxygen therapy

Middlebury, Connecticut, October 21, 2022 – O2 Concepts, a provider of innovative portable oxygen concentrator (POC) solutions dedicated to transforming how oxygen therapy is delivered, proudly launched their newest technology evolution—the Oxlife Liberty®. Built on the proven format of the company’s Oxlife Freedom! POC, the Oxlife Liberty® offers the most advanced clinical oxygen therapy available in a wearable POC, delivering both continuous flow and as much as twice the pulse dose oxygen as comparable devices on the market.

“By combining and improving on the best of our two technologies—the lightweight, compact design of the Oxlife Freedom® with the durability and reliable continuous flow of our leading Oxlife Independence®—we’ve created a truly revolutionary device that delivers the best clinical oxygen therapy to a broad range of patients,” commented Elby Beal, Managing Partner and CEO of O2 Concepts®.

The first continuous flow wearable POC available, the Oxlife Liberty® offers more than just reliable, effective oxygen therapy. It also features the company’s market-leading proprietary DNA Technology® (Dynamic Network Analysis)—an intelligent, device-initiated cellular

technology — that connects DMEs with device data for new levels of operating efficiency, asset management and inventory control and provides clinicians with critical telemedicine data for improved patient outcomes.

Oxlife Liberty® will debut at Medtrade East October 24-26 (booth #1033). The device will be available for order by DMEs beginning October 24.

For more information on Oxlife Liberty® by O2 Concepts®, visit our products page.